Why Clinical and Financial Due Diligence Has Never Been More Important in Home Health and Hospice M&A

The home health and hospice transaction market continues to evolve, but one thing has become increasingly clear: today's acquisitions carry significantly more compliance, operational, and financial risk than they did just a few years ago.

Buyers are becoming more sophisticated. Regulators are increasing scrutiny. Reimbursement pressures continue to reshape operations. In this environment, due diligence is no longer a box to check. It’s one of the most important investments made during a transaction.

Unfortunately, we're seeing a concerning trend.

At SimiTree, our Merger & Acquisition services help buyers and sellers identify risk before it becomes a costly post-transaction surprise. Documentation deficiencies, billing vulnerabilities, operational gaps, quality concerns, and financial inconsistencies can all significantly impact the value and success of an acquisition. Many of these issues can be identified through a comprehensive, independent clinical and financial due diligence review before closing, empowering organizations to make informed decisions and move forward with confidence.

Looking Beyond the Financial Statements

Financial due diligence tells part of the story.

Clinical due diligence tells you whether the business can actually sustain those financial results while remaining compliant.

Revenue often looks healthy on paper. But understanding how that revenue is generated and whether it is supported by compliant documentation, appropriate coding, accurate billing, quality clinical practices, and operational consistency is equally important.

Today’s buyers should be asking questions such as:

• Are clinical records supporting billed services?
• Are coding and documentation practices aligned with current regulations?
• What compliance risks could result in repayment obligations or audits?
• Are quality measures sustainable?
• Are there operational practices that create future financial exposure?

These questions directly affect valuation, integration planning, and long-term return on investment.

Why Independent Third-Party Reviews Matter

Experienced third-party reviewers bring an objective perspective.

Unlike internal teams who may be balancing multiple priorities during a transaction, an independent due diligence partner evaluates the organization through the lens of compliance, reimbursement, operations, and clinical quality.

The goal isn’t simply to identify problems. It’s to provide buyers with a realistic understanding of risk, opportunities for improvement, and informed decision-making before closing.

In today’s regulatory environment, that level of insight has become invaluable.

Sell-Side Due Diligence Is Equally Valuable

While buyers often focus on due diligence, sellers can benefit just as much from preparing before going to market.

Sell-side due diligence allows agencies to identify and address issues before prospective buyers discover them.

This preparation can:

• Reduce surprises during buyer diligence
• Increase buyer confidence
• Support stronger valuations
• Shorten transaction timelines
• Improve credibility throughout negotiations

Organizations that proactively assess their compliance, financial performance, and clinical operations are often better positioned for a smoother transaction process.

Preparing for Successful Transactions

Whether you're acquiring an agency or preparing your organization for sale, understanding the full operational landscape is essential.

Clinical, financial, operational, and compliance performance are interconnected. Looking at only one piece of the picture can leave significant risks undiscovered.

Our team works with buyers, sellers, investors, and advisors to provide comprehensive due diligence that extends beyond financial review. With deep expertise in home health and hospice compliance, operations, reimbursement, and clinical quality, we help organizations understand both the risks and the opportunities before transactions are finalized.

In today's M&A environment, the most successful transactions aren't simply the ones that close, they're the ones that remain successful long after the ink is dry.